6UI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arecor Therapeutics PLC

Watchlist Manager

Watchlist

Price: 0.68 EUR

Market Cap: €20.8m

A	Arecor Therapeutics PLC F:6UI	UK
	Nan Hai Corporation Ltd F:SO7	HK
	Guardion Health Sciences Inc F:0QTA	US
	CellaVision AB OTC:CLVSF	SE

Profitability Summary

Arecor Therapeutics PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-2%

Sustainable 3Y Average Gross Margin

13%

Negative Operating Margin

-110%

Negative 3Y Average Operating Margin

-149%

Operating Margin is Increasing

-305% > -110%

Negative Net Margin

-160%

Negative 3Y Average Net Margin

-287%

Net Margin is Increasing

-279% > -160%

Negative Free Cash Flow Margin

-123%

Negative 3Y Average Free Cash Flow Margin

-232%

Free Cash Flow Margin is Increasing

-330% > -123%

Negative ROE

-204%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-152%

ROIC is Increasing

-193% > -159%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.